Oxford Finance Provides $10MM Facility to Oxford BioTherapeutics
Oxford Finance closed a $10 million senior secured term loan with Oxford BioTherapeutics, an international, clinical-stage biotechnology company.
January 27, 2017
Oxford BioTherapeutics | Oxford Finance
ABF Journal